Topical Rapamycin

Archives of Dermatology
doi 10.1001/archdermatol.2010.125
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Medical Association (AMA)

Related search

Successful Treatment of Subungual Fibromas of Tuberous Sclerosis With Topical Rapamycin

JAMA Dermatology
DermatologyMedicine
2014English

Topical Rapamycin for Angiofibromas in Patients With Tuberous Sclerosis: How Does It Work in Clinical Practice?

Plastic and Aesthetic Research
2016English

Topical Rapamycin for Facial Angiofibromas in a Child With Tuberous Sclerosis Complex (TSC): A Case Report and Long-Term Follow-Up

Dermatology and Therapy
Dermatology
2017English

Is Rapamycin a Rapalog?

Nutrition and Healthy Aging
BiochemistryMedicineDieteticsFood ScienceNutrition
2019English

TOR Mutations Confer Rapamycin Resistance by Preventing Interaction With FKBP12-Rapamycin

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
1995English

Topical Rapamycin Suppresses the Angiogenesis Pathways Induced by Pulsed Dye Laser: Molecular Mechanisms of Inhibition of Regeneration and Revascularization of Photocoagulated Cutaneous Blood Vessels

Lasers in Surgery and Medicine
DermatologySurgery
2012English

Rapamycin Slows Aging in Mice

Cell Cycle
MedicineDevelopmental BiologyCell BiologyMolecular Biology
2012English

Correction: An ATP-competitive Mammalian Target of Rapamycin Inhibitor Reveals Rapamycin-Resistant Functions of mTORC1.

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2020English

Topical Anesthesia

2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy